Sep 9, 2020 | News and Trends
Niina Nuottamo, BSc, ISMPP CMPP™, Eline Hanekamp, PhD, Tim Norris, PhD, Excerpta Medica, Amsterdam, The Netherlands The COVID-19 pandemic radically changed the world of medical education as medical congresses were either canceled or switched to a virtual format. This...
Aug 25, 2020 | News and Trends
Richard Ashdown, Amplia Group; Catherine Skobe, Pfizer; Simon Fry, Springer Healthcare The impact of the COVID-19 global pandemic on healthcare systems, colleagues, friends, and loved ones has been unprecedented and, in many cases, tragic. In thinking about digital...
Jul 21, 2020 | News and Trends
Gretchen Chidester, PhD, MedThink SciCom; Alexandra Traut, PhD, AbbVie When developing a scientific communication platform (SCP), are you considering whether it will be relevant to workstreams and stakeholders worldwide? The overarching story described within an SCP...
Jun 24, 2020 | News and Trends
Allison M. Galway, MS, ISMPP CMPP™, Chameleon Communications International, Inc.*, New York, NY, USA; Sandra Harris, PhD, ISMPP CMPP™, ProEd Communications Inc.*, Beachwood, OH, USA; Dina Marenstein, PhD, ISMPP CMPP™, Chameleon Communications International, Inc.*, New...
![Patient Authorship: Three Key Questions (& Answers!) for Medical Communication Professionals [Part B]](https://i0.wp.com/www.ismpp-newsletter.com/wp-content/uploads/2020/05/Overcoming-Challenges_cropped3_shutterstock_177184073.jpg?resize=999%2C675&ssl=1)
May 26, 2020 | News and Trends
Professor Karen L. Woolley. Envision Pharma Group, Australia; University of Queensland, Brisbane, Australia; University of the Sunshine Coast, Maroochydore, Australia.Professor Beverley Yamamoto. Osaka University, Osaka, Japan; Hereditary Angioedema Japan (Registered...
![Patient Authorship: Three Key Questions (& Answers!) for Medical Communication Professionals [Part A]](https://i0.wp.com/www.ismpp-newsletter.com/wp-content/uploads/2020/05/Benefits-Risks_shutterstock_296005736.jpg?resize=1000%2C562&ssl=1)
May 13, 2020 | News and Trends
Professor Karen L. Woolley. Envision Pharma Group, Australia; University of Queensland, Brisbane, Australia; University of the Sunshine Coast, Maroochydore, Australia.Professor Beverley Yamamoto. Osaka University, Osaka, Japan; Hereditary Angioedema Japan (Registered...
